Breaks Categories: News

WednesdayJun 28, 2023 12:45 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Release of Innovative Emergency-Management System Software

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has released its exclusive Knightscope Emergency Management System (“KEMS”) platform. According to the announcement, the new software release represents the company’s ongoing commitment to reimagine public safety through the innovation of technology. The new platform supports the company’s growing nationwide system of more than 7,000 K1 blue light towers, e-phones and call boxes. The cloud-based platform is designed to interact with the wide array of telecommunication technologies, power sources, geographic locations, equipment configurations and usage patterns established in the Knightscope system. It also…

Continue Reading

WednesdayJun 28, 2023 12:32 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Ready to Execute on U.S. Government’s Shift to Near-Term Quantum Computing

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, is prepared to support the US government, as new legislation before Congress embraces all quantum technologies and pushes for near-term usage. The company announced today that recent legislation is calling for the U.S. government to develop and adopt near-term quantum computing applications with the potential to provide solutions to complex public sector optimization problems. These include electrical grid resilience, optimization of ports, global supply chain issues, emergency management and response, infrastructure, and telecommunication networks. “The country is at a unique inflection point for U.S. quantum policy,” said Dr.…

Continue Reading

WednesdayJun 28, 2023 12:22 pm

NetworkNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Share Price Target Increased in FRC Report, Receives US Patent for Cancer Immunotherapy Treatment

Ocean Biomedical (NASDAQ: OCEA), a next-generation biopharma company working to accelerate the development and commercialization of compelling new biopharma discoveries, has been spotlighted in a recent Fundamental Research Corp. (“FRC”) report. The equity analyst report increased FRC’s price target of OCEA stock to $17.63 per share, up from its March 2023 of $16.40. According to the report, the uptick was based on several things, including Ocean Biomedical’s $25 million financing facility announced last month; the company being granted two new U.S. patents and one Brazilian patent for drug and vaccine candidates targeting malaria and cancer treatment; positive results from an independent study…

Continue Reading

WednesdayJun 28, 2023 12:02 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Receives $15M Funding from Clean Fuels Fund

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has been awarded $10.5 million from Natural Resources Canada’s (“NRCan”) Clean Fuels Fund. The funding will support the development of the company’s Renewable Natural Gas (“RNG”) expansion at its Pacific Coast Renewables (“PCR”) facility. The Clean Fuels Fund is a program developed by the Canadian government to support the growth of the domestic clean fuels industry, thereby reducing Canada's greenhouse gas emissions. According to the announcement, the Pacific Coast Renewables RNG expansion project is now fully funded. The company stated that the facility expansion, which is designed to…

Continue Reading

WednesdayJun 28, 2023 11:34 am

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Sets Record Date for SRM Entertainment Spin-Off, Share Distribution

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, has announced the record date for the spin-off and distribution of common stock shares, par value $0.0001 per share, of SRM Entertainment Inc. SRM is a majority-owned subsidiary of Jupiter. According to the announcement, the record date is slated for July 7, 2023. On that date, company stockholders and holders of certain warrants will receive one share of SRM common stock, for every 19.35 shares of the company’s common stock held. The announcement noted that fractional shares would be rounded down into whole shares. The company…

Continue Reading

WednesdayJun 28, 2023 11:16 am

NetworkNewsBreaks – iHealthScreen to Host Upcoming Webinar, Report on Fundraising Efforts

iHealthScreen, an artificial intelligence (“AI”)-based health-screening company, has scheduled an exclusive Q&A webinar. CEO Alauddin Bhuiyan will host the event, which is slated for July 11, 2023, at 9 a.m. PDT. During the webinar, Bhuiyan will provide an overview of the company, including how iHealthScreen is disrupting the billion-dollar health screening market; he will also discuss the unique benefits of iHealthScreen's investment opportunity, which capitalizes on the company’s proprietary AI-driven, health-screening software. According to the announcement, iHealthScreen is one of the first companies in the world to receive CE certification and Australian and UAE health approvals for the screening of…

Continue Reading

TuesdayJun 27, 2023 2:48 pm

NetworkNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Cofounder Issued Key US Patent for Bispecific Cancer Immunotherapy Treatment

Ocean Biomedical (NASDAQ: OCEA) is reporting that a broad U.S. patent has been issued to Dr. Jack A. Elias, MD, one of the company’s scientific cofounders. The patent is for bispecific antibodies targeting chitinase 3-like-1 (“CHi3L1”) and programmed cell death protein 1 (“PD-1”). The company called it “a promising new approach that has emerged from prior breakthrough discoveries that CHi3L1 is a ‘master regulator’ of tumor growth in multiple visceral cancers.” According to the announcement, the bispecific antibody is a cutting-edge immunotherapy approach that demonstrates significant potential by combining Ocean’s proprietary anti-CHi3L1 antibody with existing immune checkpoint inhibitors that target PD-1…

Continue Reading

TuesdayJun 27, 2023 11:42 am

NetworkNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Series D Holders Exercise Final $100M Investment Option

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that on June 23, 2023, its Series D investors exercised their final option, expiring June 30, 2023, for $100 million. The move resulted in additional funding of $100 million to the company. Mullen now has more than $235 million in cash and cash equivalents on its balance sheet, which is after expending $253 million-plus for two completed acquisitions that added valuable, unencumbered assets for the majority ownership in Bollinger Motors and certain assets related to Electric Last Mile Solutions (“ELMS”). “We are in the best financial position in…

Continue Reading

TuesdayJun 27, 2023 11:28 am

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Featured in Recent Ascendiant Capital Markets Report with Buy Rating, $3.50 Per Share Price Target

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is spotlighted in a recent Ascendiant Capital Markets LLC report. According to the report, Ascendiant initiates coverage on the company's stock with a buy rating and a price target of $3.50 per share. An investment banking and equity research firm, Ascendiant focuses on high-growth sectors and has an expertise in technology, healthcare, and other emerging industries. In the report, Ascendiant shares its extensive research on and analysis of Knightscope's business model and also reports on the company’s technological advancements and market potential. Based…

Continue Reading

TuesdayJun 27, 2023 11:04 am

NetworkNewsBreaks – iHealthScreen Announces Successful Fundraising Efforts, Reaches $150K on StartEngine

iHealthScreen, an artificial intelligence (“AI”)-based health-screening company, announced that it has raised $150,000 on StartEngine. An AI-driven, HIPAA-compliant medtech company, iHealthScreen uses AI to screen for retinal diseases, stroke and heart disease and prevent blindness, deaths and disabilities. In addition to the $150,000 raised on StartEngine, iHealthScreen has raised more than $3 million in seed and NIH funding. The company offers investors a unique opportunity to capitalize on AI-driven, health-screening software developed by medical professionals. According to the company, testing for certain diseases and conditions can be cost prohibitive, and primary care providers often don't have resources to do more…

Continue Reading